BRN2, a POUerful driver of melanoma phenotype switching and metastasis.

Fane, Mitchell E; Chhabra, Yash; Smith, Aaron G; Sturm, Richard A

Fane, Mitchell E; Chhabra, Yash; Smith, Aaron G; Sturm, Richard A.

Afiliação

Fane ME; School of Biomedical Sciences, Institute of Health and Biomedical Innovation at the Translational Research Institute, Queensland University of Technology, Brisbane, QLD, Australia.
Chhabra Y; Dermatology Research Centre, UQ Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia.
Smith AG; School of Biomedical Sciences, Institute of Health and Biomedical Innovation at the Translational Research Institute, Queensland University of Technology, Brisbane, QLD, Australia.
Sturm RA; Dermatology Research Centre, UQ Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia.

Pigment Cell Melanoma Res ; 32(1): 9-24, 2019 01.

Article em En | MEDLINE | ID: mdl-29781575

Assuntos

Melanoma/patologia; Fatores do Domínio POU/metabolismo; Animais; Humanos; Modelos Biológicos; Invasividade Neoplásica; Metástase Neoplásica; Fenótipo

Palavras-chave

CDKN2A; POU; epigenetic; phenotype switching; transcription factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google